Cancer Research Articles
-
Julio Lautersztain, MD Co-Authors Study on Novel Co-Inheritance of Beta Globin and Spectrin MutationsJulio Lautersztain, MD, medical oncologist who practices at Florida Cancer Specialists & Research Institute (FCS) locations in Tampa and Brandon, is co-author of a new study entitled “Novel mechanism of hereditary pyropoikilocytosis phenotype due to co‐inheritance of β globin and α spectrin mutations.” -
Florida Cancer Specialists & Research Institute Medical Oncologist Paresh Patel, MD Named 2021 FLASCO “Advocate of the Year”Pareshkumar Patel, MD, medical oncologist with Florida Cancer Specialists & Research Institute (FCS), is the recipient of the 2021 FLASCO Advocate of the Year Award. -
Florida Cancer Specialists & Research Institute Participates in FLASCO 2021 Spring SummitPhysicians and leaders of Florida Cancer Specialists & Research Institute (FCS) are participating in the Florida Society of Clinical Oncology (FLASCO) 2021 Business of Oncology Summit & Spring Session being held in Kissimmee, FL on April 16 & 17.
-
Florida Cancer Specialists & Research Institute Physicians Featured Speakers at Community Oncology Alliance Spring SessionPhysicians, clinicians and administrative leaders of Florida Cancer Specialists & Research Institute (FCS) will be participating in the virtual 2021 Community Oncology Conference hosted by the Community Oncology Alliance (COA) on April 8 & 9, 2021. -
Florida Cancer Specialists Lecanto Office Receives Blanket Warmer DonationThe donation of a blanket warmer machine will provide added comfort to patients who receive care at Florida Cancer Specialists & Research Institute’s (FCS) Lecanto location. -
Florida Cancer Specialists & Research Institute Appoints Gustavo Fonseca, MD, FACP as Medical Director of Clinical Research ProgramFlorida Cancer Specialists & Research Institute (FCS) has named Gustavo “Gus” Fonseca, MD, FACP as Medical Director of the Clinical Research Program. -
Gustavo Fonseca, MD & James Reeves, MD Co-Author Study Published in Journal of Clinical OncologyClinical Study Evaluates Efficacy and Safety of Umbralisib in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma -
Florida Cancer Specialists & Research Institute Collaborates with County Health Departments to Provide Covid-19 Vaccines to High-Risk IndividualsFCS is providing COVID-19 vaccines to its front-line health care workers and patients determined to be at high risk and extremely vulnerable to COVID-19.
Health & Wellness
January 23, 2025
Challenging Family Dynamics and Cancer
Learn about the loneliness cancer patients often face within their families and gain insights on how to offer more effective help and understanding during their challenging battle.
Read Article